Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

121.93 +0.26 (+0.21%)
Official Closing Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,926,314
Open 121.51
Bid (Size) 121.93 (1,000)
Ask (Size) 122.20 (1,100)
Prev. Close 121.67
Today's Range 120.95 - 122.80
52wk Range 66.66 - 126.50
Shares Outstanding 541,500
Dividend Yield 0.09%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution
New York, NY – December 9, 2025 – The S&P 500 Healthcare sector found itself in a precarious position today, emerging as the biggest underperformer among its peers. While the broader S&P 500 index... 
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
Eaton, FTAI Aviation And More On CNBC's 'Final Trades' ↗
FTAI Aviation (NASDAQ: FTAI) is recommended by investment experts to diversify portfolios beyond tech, while Eaton (NYSE: ETN) and SPDR S&P Biotech ETF (NYSE: XBI) show promising price action. SoFi's... 
Via Benzinga
Topics ETFs Stocks

Performance

YTD
+33.2%
+33.2%
1 Month
+1.7%
+1.7%
3 Month
+21.7%
+21.7%
6 Month
+46.8%
+46.8%
1 Year
+35.6%
+35.6%

More News

Read More
News headline image
Biotech Insiders Are Spending Billions. Trump Favors Less Oversight. One Biotech ETF Could Ride the Surge. ↗
Via The Motley Fool
Topics ETFs Economy Government
Cidara Therapeutics Granted FDA Breakthrough Therapy Designation For Flu-Preventing Antiviral ↗
Via Stocktwits
White House Clarifies Recent Pharmaceutical Tariffs Exempt Countries with Trade Agreements: Report ↗
Via Stocktwits
News headline image
Money Moving Into Healthcare Not AI; Four Fed Presidents Do Not Want a Rate Cut; Euphoria Wearing Off ↗
Via Benzinga
Topics Economy
News headline image
Taiwan Semiconductor, HealthEquity, Cboe Global Markets And More: CNBC's 'Final Trades' ↗
Via Benzinga
News headline image
Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? ↗
Via Benzinga
Topics ETFs
News headline image
FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’ ↗
Via Stocktwits
Topics Lawsuit
News headline image
Top 6 ETFs To Watch As Wall Street's Strongest Six Months Begin ↗
Via Benzinga
Topics Artificial Intelligence ETFs
News headline image
Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles ↗
Via Benzinga
News headline image
Why Avidity Biosciences Stock Is Jumping Over 43% In Premarket Today ↗
Via Stocktwits
News headline image
Biotech Boom: Strategic Realignments and AI Integration Fuel Investor Focus, Signaling Broader Market Shifts
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures ↗
Via Benzinga
News headline image
4 Biotech Stocks Seeing Explosive Momentum Gains ↗
Via Benzinga
Topics ETFs Stocks
News headline image
How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline ↗
Via Benzinga
Topics ETFs Government
News headline image
SciSparc And AutoMax Call Off Merger ↗
Via Benzinga
Eli Lilly Stock Jumps As Trump’s Drug Price Crackdown Spurs Sector Rally; Analysts Say Pfizer Deal Sets Template For Big Pharma ↗
Via Stocktwits
Topics Government
News headline image
Pharma Tariffs Back In Spotlight On New Trump Threat ↗
Via Investor's Business Daily
Topics ETFs Government World Trade
Trump Shocks Pharma With 100% Tariff On Imported Drugs Unless Companies Build In America ↗
Via Stocktwits
Topics Government
News headline image
uniQure Stock Rises Pre-Market After Investigational Huntington’s Disease Drug Slows Disease In Trial ↗
Via Stocktwits
News headline image
CrowdStrike, SoFi, Clearway Energy And More: CNBC's 'Final Trades' ↗
Via Benzinga
Topics ETFs Stocks
News headline image
As the Fed Pivots, These 3 ETFs Are Positioned to Outperform ↗
Via The Motley Fool
Topics ETFs Economy
News headline image
Trump's Biotech Playbook Ignites $350 Billion Investment Blitz ↗
Via Benzinga
Topics ETFs Government
News headline image
Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy. ↗
Via Investor's Business Daily
Topics ETFs Government Intellectual Property

Frequently Asked Questions

Is State Street SPDR S&P Biotech ETF publicly traded?
Yes, State Street SPDR S&P Biotech ETF is publicly traded.
What exchange does State Street SPDR S&P Biotech ETF trade on?
State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange
What is the ticker symbol for State Street SPDR S&P Biotech ETF?
The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange
What is the current price of State Street SPDR S&P Biotech ETF?
The current price of State Street SPDR S&P Biotech ETF is 121.93
When was State Street SPDR S&P Biotech ETF last traded?
The last trade of State Street SPDR S&P Biotech ETF was at 12/31/25 04:00 PM ET
What is the market capitalization of State Street SPDR S&P Biotech ETF?
The market capitalization of State Street SPDR S&P Biotech ETF is 66.03M
How many shares of State Street SPDR S&P Biotech ETF are outstanding?
State Street SPDR S&P Biotech ETF has 66M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.